161 related articles for article (PubMed ID: 3492025)
1. Inhibition of C1q binding to antigen-antibody complexes by a factor in rheumatoid arthritis serum.
Niven IP; Whaley K
Rheumatol Int; 1986; 6(5):205-8. PubMed ID: 3492025
[TBL] [Abstract][Full Text] [Related]
2. C1q-bearing immune complexes detected by a monoclonal antibody to human C1q in rheumatoid arthritis sera and synovial fluids.
Antes U; Heinz HP; Schultz D; Brackertz D; Loos M
Rheumatol Int; 1991; 10(6):245-50. PubMed ID: 2041983
[TBL] [Abstract][Full Text] [Related]
3. Association of C1q- and conglutinin-binding immune complexes with high consumption of alpha-2-macroglobulin in synovial fluids of patients with rheumatoid arthritis.
Borth W; Menzel JE
Int Arch Allergy Appl Immunol; 1984; 75(1):92-6. PubMed ID: 6204949
[TBL] [Abstract][Full Text] [Related]
4. Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.
Carsons SE; Schwartzman S; Diamond HS; Berkowitz E
Clin Exp Immunol; 1988 Apr; 72(1):37-42. PubMed ID: 3135129
[TBL] [Abstract][Full Text] [Related]
5. [Synovial level of interleukin 1 and C3a in chronic polyarthritis, psoriatic arthritis and activated arthritis].
Hermann E; Vogt P; Hagmann W; Dunky A; Müller W
Z Rheumatol; 1988; 47(1):20-5. PubMed ID: 3259355
[TBL] [Abstract][Full Text] [Related]
6. Complement mediated inhibition of immune precipitation in rheumatoid arthritis: studies on interaction of heat aggregated IgG with IgM rheumatoid factor.
O'Sullivan MM; Amos N; Williams BD
Ann Rheum Dis; 1988 Aug; 47(8):675-80. PubMed ID: 3261968
[TBL] [Abstract][Full Text] [Related]
7. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
[TBL] [Abstract][Full Text] [Related]
8. Rheumatoid factor isotypes and circulating immune complexes in rheumatoid arthritis.
Zlabinger GJ; Haberhauer G; Dax K; Menzel EJ; Bröll H
Clin Exp Rheumatol; 1990; 8(2):113-9. PubMed ID: 2338008
[TBL] [Abstract][Full Text] [Related]
9. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of Clq binding activity by IgM rheumatoid factor.
Zilberfarb JL; Andrews BS; Young AC; Davis JS
J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of C1q - binding to collagen - anticollagen immune complexes in synovial fluids of RA-patients.
Menzel J; Steffen C
Z Rheumatol; 1982; 41(2):47-9. PubMed ID: 6285637
[TBL] [Abstract][Full Text] [Related]
12. Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.
Bedwell AE; Elson CJ; Carter SD; Dieppe PA; Hutton CW; Czudek R
Ann Rheum Dis; 1987 Jan; 46(1):55-64. PubMed ID: 3492971
[TBL] [Abstract][Full Text] [Related]
13. An analysis of the fluid phase C1q binding assay. The effect of endogenous C1q on the precipitation and detection of an immune complex model.
Jacobs RJ; Mocharla R
J Immunol Methods; 1988 May; 109(2):265-75. PubMed ID: 3258897
[TBL] [Abstract][Full Text] [Related]
14. Measurement of immune complexes with the liquid phase C1q binding assay: ten years experience in a routine diagnostic laboratory.
Roberts-Thomson PJ; Neoh SH; Kennedy A; Smith MD; O'Donnell J; Bradley J
Asian Pac J Allergy Immunol; 1987 Dec; 5(2):149-54. PubMed ID: 3502389
[TBL] [Abstract][Full Text] [Related]
15. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
[TBL] [Abstract][Full Text] [Related]
16. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
[TBL] [Abstract][Full Text] [Related]
17. Isolation of C1q-binding immune complexes by affinity chromatography and desorption with a diaminoalkyl compound.
Svehag SE; Burger D
Acta Pathol Microbiol Scand C; 1976 Feb; 84(1):45-52. PubMed ID: 773099
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of C1q functions by RHP, a protein elevated in sera from patients with rheumatoid arthritis.
Rosano CL; Braun CB; Hechemy KE; Parhami N; Satoh PS; Hurwitz C
Complement; 1988; 5(2):57-64. PubMed ID: 3259913
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic alteration of C1q, the collagen-like subcomponent of the first component of complement, leads to cross-reactivity with type II collagen.
Heinz HP; Brackertz D; Loos M
FEBS Lett; 1988 Feb; 228(2):332-6. PubMed ID: 2830144
[TBL] [Abstract][Full Text] [Related]
20. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
Pearlstein E; Sorvillo J; Gigli I
J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
